Skip to content
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Gastroenterology

Living with AIE and Monitoring

At a Glance

Living with autoimmune enteropathy requires individualized follow-up of symptoms, hydration, nutrition, laboratory results, and sometimes biopsies. Infection precautions, emergency plans, output tracking, and intestinal-failure support can help protect health during long-term treatment.

Living with autoimmune enteropathy (AIE) is a marathon, not a sprint. Because it is a chronic condition, the focus of care shifts from stabilizing an emergency to maintaining long-term health and preventing complications [1][2]. Success in the “maintenance phase” requires a partnership between you and a specialized medical team to monitor the immune system, the gut, and the body’s nutritional status [3].

The Role of Surveillance Biopsies

Unlike some conditions where symptoms alone guide treatment, AIE may require looking directly at the tissue to understand what is happening. Surveillance biopsies (repeat endoscopies) are sometimes used to check for mucosal healing—the restoration of the intestinal villi and the return of specialized cells like goblet cells [4].

  • Clinical vs. Histologic Response: It is possible to feel better while the intestine is still showing signs of immune attack [5]. However, there is no universally accepted surveillance interval or validated treat-to-target strategy. Endoscopy frequency is individualized—often considered for an unclear diagnosis, nonresponse, or suspected relapse—because repeat procedures carry procedural and anesthesia burdens. Symptoms, hydration, laboratory results, and stool testing are often assessed first [5][6].
  • Monitoring Relapse: AIE can be unpredictable. In one retrospective study, nearly 40% of patients experienced a relapse within four years [6]. If symptoms return, a biopsy should not automatically be the first step. Your doctor should urgently assess for infection, medication side effects, diet adherence, dehydration, and electrolyte abnormalities before recommending another endoscopy [7].

Nutritional Monitoring and Support

Because the small intestine is the body’s primary “absorber,” AIE patients are at high risk for micronutrient deficiencies even when they are eating well [8].

Your care team will likely monitor a specific panel of markers, including:

  • Albumin and Electrolytes: Low albumin (a protein) and imbalances in electrolytes (like sodium and potassium) are common and can lead to swelling or kidney strain [9][10].
  • Trace Minerals: Deficiencies in zinc and selenium are frequently reported and may persist even with standard supplements [8].
  • Vitamins: Fat-soluble vitamins (A, D, E, and K), as well as B12 and folate, must be checked regularly [8][7].
  • Bone Health: Long-term steroid use and malabsorption can weaken bones, so periodic DEXA scans (bone density tests) may be recommended [11].

Risks of Long-Term Immunosuppression

The medications used to control AIE “turn down” the immune system, which carries necessary trade-offs.

  • Infection Risk: This is a major concern. Severe infections and sepsis have been reported in AIE patients on chronic immunosuppression [12][13].
    • Urgent Action Plan: You must have a written contact pathway. If you develop a fever, chills or shaking with a central line, fainting, confusion, inability to keep fluids down, blood in stool, or rapidly increasing ostomy output, do not wait for a routine appointment. Seek emergency care immediately.
    • Vaccinations: Vaccination should be based on your age, documented splenic function (as some conditions like celiac or rare AIE complications can affect the spleen), and national guidance. Note that live vaccines may be unsafe during significant immunosuppression [14].
  • Malignancy Risk: While rare, there is a small reported risk of secondary cancers, such as non-Hodgkin lymphoma, in patients on long-term immunosuppression [6][7]. This risk is largely dependent on the specific drugs used rather than AIE itself, and there is no routine AIE-specific lymphoma screening protocol.

Managing Daily Life: Diarrhea and Ostomy Care

For a subset of patients—particularly those with an ostomy or intestinal failure—the day-to-day reality involves managing high-volume, watery diarrhea or high ostomy output, which can sometimes exceed 4 liters per day [15].

  • Output Tracking: Keeping a daily log of output and weight helps establish your individualized baseline. Thresholds for concern should be based on this personal baseline rather than a universal number [16][15].
  • Hydration Strategies: Standard antidiarrheal drugs (like loperamide) should be clinician-directed, particularly if you have a fever, blood in the stool, or suspect an infection [17]. Instead, the focus is on individualized oral rehydration using prescribed solutions (not unrestricted plain water) and aggressive control of inflammation [10][1].
  • Intestinal Failure Care: If the bowel cannot sustain the body through eating alone, long-term TPN (Total Parenteral Nutrition) becomes a life-saving bridge. Intestinal transplant is a rare, high-risk option considered only for selected, irreversible intestinal failure, not an expected next step [18][19].

Living with AIE requires constant vigilance, but with a dedicated team and careful monitoring, many patients can achieve stability and a significantly improved quality of life [19][20].

Common questions in this guide

How often do people with autoimmune enteropathy need follow-up biopsies?
There is no universally accepted schedule for repeat biopsies in autoimmune enteropathy. The decision is individualized based on symptoms, hydration, laboratory and stool results, uncertainty about the diagnosis, treatment response, or suspected relapse, while also considering the burdens of endoscopy and anesthesia.
Which nutrition tests are important for autoimmune enteropathy?
Monitoring may include albumin and electrolytes, zinc, selenium, vitamins A, D, E, and K, vitamin B12, and folate. Your team may also recommend bone-density testing because malabsorption and long-term steroid use can weaken bones.
Can I feel better even if autoimmune enteropathy is still active?
Yes. Symptoms can improve while the intestinal lining still shows inflammation or immune injury, so feeling better does not always prove that the tissue has healed. Clinicians use your symptoms, hydration, laboratory results, stool testing, and sometimes biopsy findings together.
What symptoms require emergency care while I am taking immunosuppressive medicine?
Seek emergency care for fever, chills or shaking with a central line, fainting, confusion, inability to keep fluids down, blood in the stool, or rapidly increasing ostomy output. These symptoms can signal serious infection, dehydration, or another complication that should not wait for a routine appointment.
How should I manage diarrhea or high ostomy output with autoimmune enteropathy?
Track your daily weight and stool or ostomy output so you know your personal baseline. Use the oral rehydration solution prescribed by your care team, and ask a clinician before taking loperamide or another antidiarrheal, especially if you have fever, blood in the stool, or possible infection.
Does long-term immunosuppression increase the risk of infection or cancer?
Long-term immunosuppression can increase the risk of serious infections, and some medicines have been associated with a small risk of secondary cancers such as non-Hodgkin lymphoma. Ask your clinician about medication-specific monitoring, vaccination, and warning signs; there is no routine autoimmune-enteropathy-specific lymphoma screening protocol.
When is TPN used in autoimmune enteropathy, and is an intestinal transplant always needed?
Total parenteral nutrition, or TPN, may provide essential nutrition when the intestine cannot support the body through eating alone. Intestinal transplant is a rare, high-risk option reserved for selected patients with irreversible intestinal failure and is not an expected next step for everyone.

Get notified when new evidence is published on Primary autoimmune enteropathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (20)
  1. 1

    Autoimmune Enteropathy: An Updated Review with Special Focus on Stem Cell Transplant Therapy.

    Ahmed Z, Imdad A, Connelly JA, Acra S

    Digestive diseases and sciences 2019; (64(3)):643-654 doi:10.1007/s10620-018-5364-1.

    PMID: 30415406
  2. 2

    Comprehensive insights into pathogenesis, diagnosis, treatment, and prognosis in adult autoimmune enteropathy.

    Li M, Xu T, Ruan G, et al.

    Orphanet journal of rare diseases 2025; (20(1)):208 doi:10.1186/s13023-025-03731-2.

    PMID: 40317016
  3. 3

    Demystifying autoimmune small bowel enteropathy.

    Elli L, Ferretti F, Vaira V

    Current opinion in gastroenterology 2019; (35(3)):243-249 doi:10.1097/MOG.0000000000000515.

    PMID: 30747741
  4. 4

    Neuroendocrine Cells Are Commonly Absent in the Intestinal Crypts in Autoimmune Enteropathy.

    Lee HE, Yuan L, Wu TT

    The American journal of surgical pathology 2020; (44(8)):1130-1136 doi:10.1097/PAS.0000000000001516.

    PMID: 32590456
  5. 5

    Reduction in mucosal phosphorylated STAT3 under therapy with JAK inhibitor in STAT3 gain of function mutation - a case study.

    Oberli R, Mookhoek A, Denier D, et al.

    Virchows Archiv : an international journal of pathology 2026; doi:10.1007/s00428-026-04409-1.

    PMID: 41555056
  6. 6

    Clinical manifestations, diagnosis and long-term prognosis of adult autoimmune enteropathy: Experience from Peking Union Medical College Hospital.

    Li MH, Ruan GC, Zhou WX, et al.

    World journal of gastroenterology 2024; (30(19)):2523-2537 doi:10.3748/wjg.v30.i19.2523.

    PMID: 38817655
  7. 7

    Intestinal T-cell lymphoma with enteropathy-associated T-cell lymphoma-like features arising in the setting of adult autoimmune enteropathy.

    Ciccocioppo R, Croci GA, Biagi F, et al.

    Hematological oncology 2018; (36(2)):481-488 doi:10.1002/hon.2494.

    PMID: 29446107
  8. 8

    Adult autoimmune enteropathy presenting initially with acquired Acrodermatitis Enteropathica: a case report.

    Lie E, Sung S, Yang SH

    BMC dermatology 2017; (17(1)):7 doi:10.1186/s12895-017-0059-4.

    PMID: 28521835
  9. 9

    Relieving the discrimination dilemma of adult autoimmune enteropathy and common variable immunodeficiency disease: two rare causes of chronic diarrhea and small intestinal villous atrophy.

    Li M, Wang Q, Chen Y, et al.

    Clinical rheumatology 2025; (44(8)):3353-3367 doi:10.1007/s10067-025-07523-8.

    PMID: 40622608
  10. 10

    A man in his fifties with chronic diarrhoea and weight loss.

    Sarna VK, Lunding J, Løberg EM, Solberg IC

    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 2020; (140(11)) doi:10.4045/tidsskr.19.0812.

    PMID: 32815334
  11. 11

    Long-term efficacy and safety of different corticosteroid courses plus mycophenolate mofetil for autoimmune encephalitis with neuronal surface antibodies without tumor.

    Li D, Huang T, Zhang F, et al.

    Frontiers in immunology 2023; (14()):1195172 doi:10.3389/fimmu.2023.1195172.

    PMID: 37503335
  12. 12

    Autoimmune enteropathy in adults: a case report and literature review.

    Xu S, Dou X, Wang L, Yu C

    AME case reports 2025; (9()):99 doi:10.21037/acr-25-24.

    PMID: 40761215
  13. 13

    Long-term Prognosis of Nonceliac Enteropathies and a Score to Identify Patients With Poor Outcomes: A 30-year Multicenter Longitudinal Study.

    Schiepatti A, Maimaris S, Scalvini D, et al.

    The American journal of gastroenterology 2025; (120(11)):2660-2669 doi:10.14309/ajg.0000000000003331.

    PMID: 39878474
  14. 14

    Defective spleen function in autoimmune gastrointestinal disorders.

    Giuffrida P, Aronico N, Rosselli M, et al.

    Internal and emergency medicine 2020; (15(2)):225-229 doi:10.1007/s11739-019-02129-w.

    PMID: 31214883
  15. 15

    Autoimmune Enteropathy in an Ulcerative Colitis Patient.

    Rodriguez NJ, Gupta N, Gibson J

    ACG case reports journal 2018; (5()):e78 doi:10.14309/crj.2018.78.

    PMID: 30465008
  16. 16

    Clinical characteristics and management of autoimmune enteropathy in children: case reports and literature review.

    Jin M, Gong Y, Liu W, Zhong X

    BMC pediatrics 2023; (23(1)):601 doi:10.1186/s12887-023-04435-x.

    PMID: 38017413
  17. 17

    Autoimmune Enteritis in an Adult With Psoriatic Arthritis, Successfully Treated With Glucocorticoids and Adalimumab.

    Avalos E, Mohamed A, Shapiro J, et al.

    Cureus 2024; (16(12)):e74965 doi:10.7759/cureus.74965.

    PMID: 39744276
  18. 18

    Isolated Intestine Transplantation for Autoimmune Enteropathy: A Case Report.

    Soma D, Saxena R, Arman ME, et al.

    Transplantation proceedings 2020; (52(9)):2835-2838 doi:10.1016/j.transproceed.2020.08.007.

    PMID: 32854966
  19. 19

    Successful Treatment of Refractory Autoimmune Enteropathy With Ustekinumab.

    Scheid JF, Misdraji J, Nath BJ, Yarze JC

    ACG case reports journal 2021; (8(1)):e00520 doi:10.14309/crj.0000000000000520.

    PMID: 33457439
  20. 20

    Adult-Onset Autoimmune Enteropathy in an European Tertiary Referral Center.

    van Wanrooij RLJ, Neefjes-Borst EA, Bontkes HJ, et al.

    Clinical and translational gastroenterology 2021; (12(8)):e00387 doi:10.14309/ctg.0000000000000387.

    PMID: 34333499

This page is for informational purposes only and does not constitute medical advice. Your gastroenterology and nutrition team should tailor monitoring, medications, hydration, and emergency plans to your needs.